Elevated endogenous erythropoietin concentrations are associated with increased risk of brain damage in extremely preterm neonates

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Steven, J Korzeniewski ^a,b,c   Elizabeth, Allred ^d   J, Wells Logan ^e   Raina, N Fichorova ^f   Stephen, Engelke ^g   Karl, C K Kuban ^h   T, Michael O'Shea ⁱ   Nigel, Paneth ^c   Mari, Holml ^j,k   Olaf, Dammannl ^k,l   Alan, Leviton ^d  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MICHIGAN STATE UNIVERSITY   (United States)

^d BOSTON CHILDREN S HOSPITAL   (United States)

^e NATIONWIDE CHILDREN S HOSPITAL   (United States)

^f BRIGHAM AND WOMEN S HOSPITAL   (United States)

^g EAST CAROLINA UNIVERSITY   (United States)

^h BOSTON MEDICAL CENTER   (United States)

ⁱ WAKE FOREST SCHOOL OF MEDICINE   (United States)

^j NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^k TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^l HANNOVER MEDICAL SCHOOL   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CXCL11 CHEMOKINE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; ERYTHROPOIETIN; GELATINASE B; INTERCELLULAR ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 3; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; INTERLEUKIN 8; INTERSTITIAL COLLAGENASE; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 4; MYELOPEROXIDASE; RANTES; SERUM AMYLOID A; SOMATOMEDIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ARTICLE; BRAIN DAMAGE; BRAIN VENTRICLE DILATATION; CEREBRAL PALSY; DEVELOPMENTAL SCREENING; DEVELOPMENTAL STAGE; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; MENTAL FUNCTION; MICROCEPHALY; NEWBORN; PERINATAL PERIOD; PREMATURITY; PROTEIN BLOOD LEVEL; PSYCHOMOTOR ACTIVITY; RISK ASSESSMENT; SYSTEMIC DISEASE; BLOOD; BRAIN INJURY; COMPLICATION; CONFIDENCE INTERVAL; INFLAMMATION; ODDS RATIO; PATHOLOGY; PATHOPHYSIOLOGY; PSYCHOMOTOR PERFORMANCE; RISK FACTOR; STATISTICAL MODEL;

BRAIN INJURIES; CEREBRAL PALSY; CONFIDENCE INTERVALS; ERYTHROPOIETIN; GESTATIONAL AGE; HUMANS; INFANT, EXTREMELY PREMATURE; INFANT, NEWBORN; INFLAMMATION; LOGISTIC MODELS; MICROCEPHALY; ODDS RATIO; PSYCHOMOTOR PERFORMANCE; RISK FACTORS;

EID: 84925850314     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0115083     Document Type: Article

References (49)

1. Masuda S, Okano M, Yamagishi K, Nagao M, Ueda M, et al. (1994) A novel site of erythropoietin production. Oxygen-dependent production in cultured rat astrocytes. J Biol Chem 269: 19488-19493. PMID: 8034718
2. Morishita E, Masuda S, Nagao M, Yasuda Y, Sasaki R (1997) Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons, and erythropoietin prevents in vitro glutamate-induced neuronal death. Neuroscience 76: 105-116. PMID: 8971763
3. Bierer R, Peceny MC, Hartenberger CH, Ohls RK (2006) Erythropoietin concentrations and neurodevelopmental outcome in preterm infants. Pediatrics 118: e635-640. PMID: 16908620
4. Neubauer A-P, Voss W, Wachtendorf M, Jungmann T (2010) Erythropoietin Improves Neurodevelopmental Outcome of Extremely Preterm Infants. Annals of Neurology 67: 657-666. doi: 10.1002/ana. 21977 PMID: 20437563
5. Ohls RK, Kamath-Rayne BD, Christensen RD, Wiedmeier SE, Rosenberg A, et al. (2014) Cognitive Outcomes of Preterm Infants Randomized to Darbepoetin, Erythropoietin, or Placebo. Pediatrics 133: 1023-1030. doi: 10.1542/peds.2013-4307 PMID: 24819566
6. Zhu C, Kang W, Xu F, Cheng X, Zhang Z, et al. (2009) Erythropoietin Improved Neurologic Outcomes in Newborns With Hypoxic-Ischemic Encephalopathy. Pediatrics 124: E218-E226. doi: 10.1542/peds. 2008-3553 PMID: 19651565
7. Brown MS, Eichorst D, LaLa-Black B, Gonzalez R (2009) Higher Cumulative Doses of Erythropoietin and Developmental Outcomes in Preterm Infants. Pediatrics 124: E681-E687. doi: 10.1542/peds. 2008-2701 PMID: 19786428
8. th post-menstrual week. Early Human Development 87: 325-330. doi: 10.1016/j.earlhumdev.2011. 01.043 PMID: 21334149
9. Leviton A, Kuban K, O'Shea TM, Paneth N, Fichorova R, et al. (2011) The Relationship between Early Concentrations of 25 Blood Proteins and Cerebral White Matter Injury in Preterm Newborns: The ELGAN Study. The Journal of Pediatrics 158: 897-903.e895. doi: 10.1016/j.jpeds.2010.11.059 PMID: 21238986
10. O'Shea TM, Allred EN, Kuban KCK, Dammann O, Paneth N, et al. (2012) Elevated Concentrations of Inflammation-Related Proteins in Postnatal Blood Predict Severe Developmental Delay at 2 Years of Age in Extremely Preterm Infants. Journal of Pediatrics 160: 395-401. doi: 10.1016/j.jpeds.2011.08. 069 PMID: 22000304
11. O'Shea TM, Shah B, Allred EN, Fichorova RN, Kuban KC, et al. (2013) Inflammation-initiating illnesses, inflammation-related proteins, and cognitive impairment in extremely preterm infants. Brain, Behavior, and Immunity 29: 104-112. doi: 10.1016/j.bbi.2012.12.012 PMID: 23295265
12. Leviton A, Fichorova RN, O'Shea TM, Kuban K, Paneth N, et al. (2013) Two-hit model of brain damage in the very preterm newborn: small for gestational age and postnatal systemic inflammation. Pediatric Research 73: 362-370. doi: 10.1038/pr.2012.188 PMID: 23364171
13. Lee SH, Li C, Lim SW, Ahn KO, Choi BS, et al. (2005) Attenuation of interstitial inflammation and fibrosis by recombinant human erythropoietin in chronic cyclosporine nephropathy. Am J Nephrol 25: 64-76. PMID: 15746540
14. Contaldo C, Lindenblatt N, Elsherbiny A, Hogger DC, Borozadi MK, et al. (2011) Erythropoietin requires endothelial nitric oxide synthase to counteract TNF-[alpha]-induced microcirculatory dysfunction in murine striated muscle. Shock 35: 315-321. doi: 10.1097/SHK.0b013e3181fd0700 PMID: 20926979
15. Wells Logan J, Allred EN, Fichorova RN, Engelke S, Dammann O, et al. (2014) Endogenous erythropoietin varies significantly with inflammation-related proteins in extremely premature newborns. Cytokine 69: 22-28. doi: 10.1016/j.cyto.2014.04.009 PMID: 25022958
16. O'Shea TM, Allred EN, Dammann O, Hirtz D, Kuban KC, et al. (2009) The ELGAN study of the brain and related disorders in extremely low gestational age newborns. Early Hum Dev 85: 719-725. doi: 10. 1016/j.earlhumdev.2009.08.060 PMID: 19765918
17. Yudkin PL, Aboualfa M, Eyre JA, Redman CW, Wilkinson AR (1987) New birthweight and head circumference centiles for gestational ages 24 to 42 weeks. Early Hum Dev 15: 45-52. PMID: 3816638
18. Leviton A, Paneth N, Reuss ML, Susser M, Allred EN, et al. (1999) Maternal infection, fetal inflammatory response, and brain damage in very low birthweight infants. Pediatric Research 46: 566-575. PMID: 10541320
19. Hecht JL, Fichorova RN, Tang VF, Allred EN, McElrath TF, et al. (2011) Relationship between neonatal blood protein profiles and placenta histologic characteristics in ELGANs. Pediatr Research 69: 68-73. doi: 10.1203/PDR.0b013e3181fed334 PMID: 20921924
20. Leviton A, Fichorova R, Yamamoto Y, Allred EN, Dammann O, et al. (2011) Inflammation-related proteins in the blood of extremely low gestational age newborns. The contribution of inflammation to the appearance of developmental regulation. Cytokine 53: 66-73. doi: 10.1016/j.cyto.2010.09.003 PMID: 20934883
21. Fichorova RN, Trifonova RT, Gilbert RO, Costello CE, Hayes GR, et al. (2006) Trichomonas vaginalis lipophosphoglycan triggers a selective upregulation of cytokines by human female reproductive tract epithelial cells. Infect Immun 74: 5773-5779. PMID: 16988255
22. Fichorova RN, Richardson-Harman N, Alfano M, Belec L, Carbonneil C, et al. (2008) Biological and technical variables affecting immunoassay recovery of cytokines from human serum and simulated vaginal fluid: a multicenter study. Anal Chem 80: 4741-4751. doi: 10.1021/ac702628q PMID: 18484740
23. Fichorova RN, Onderdonk AB, Yamamoto H, M.L. D, Dubois AM, et al. (2011) Microbe-specific modulation of inflammatory response in extremely low gestational age newborns. mBio 2: e00280-00210. doi: 10.1128/mBio.00280-11 PMID: 22186612
24. McElrath TF, Fichorova RN, Allred EN, Hecht JL, Ismail MA, et al. (2011) Blood protein profiles of infants born before 28 weeks differ by pregnancy complication. Am J Obstet Gynecol 204: 418.e411-418.e412. doi: 10.1016/j.ajog.2010.12.010 PMID: 21349490
25. Fichorova RN, Onderdonk AB, Yamamoto H, Delaney ML, DuBois AM, et al. (2011) Maternal microbespecific modulation of inflammatory response in extremely low-gestational-age newborns. MBio 2: e00280-00210. doi: 10.1128/mBio.00280-11 PMID: 22186612
26. Kuban K, Adler I, Allred EN, Batton D, Bezinque S, et al. (2007) Observer variability assessing US scans of the preterm brain: the ELGAN study. Pediatr Radiol 37: 1201-1208 PMID: 17901950
27. Bayley N (1993) Bayley Scales of Infant Development-II.: Psychological Corporation, San Antonio, TX.
28. Kuban KC, O'Shea M, Allred E, Leviton A, Gilmore H, et al. (2005) Video and CD-ROM as a training tool for performing neurologic examinations of 1-year-old children in a multicenter epidemiologic study. J Child Neurol 20: 829-831. PMID: 16417880
29. CDC (2007) CDC Growth Charts: United States http://www.cdc.gov/nchs/data/nhanes/growthcharts/ zscore/zhcageinf.xls.
30. Grivennikov S, Karin E, Terzic J, Mucida D, Yu GY, et al. (2009) IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer. Cancer Cell 15: 103-113. doi: 10.1016/j.ccr.2009.01.001 PMID: 19185845
31. O'Shea TM, Allred EN, Kuban KC, Dammann O, Paneth N, et al. (2012) Elevated concentrations of in-flammation-related proteins in postnatal blood predict severe developmental delay at 2 years of age in extremely preterm infants. J Pediatr 160: 395-401 e394. doi: 10.1016/j.jpeds.2011.08.069 PMID: 22000304
32. Kuban KC, O'Shea TM, Allred EN, Paneth N, Hirtz D, et al. (2014) Systemic Inflammation and Cerebral Palsy Risk in Extremely Preterm Infants. J Child Neurol [Epub ahead of print, March 18].
33. Wu YW, Bauer LA, Ballard RA, Ferriero DM, Glidden DV, et al. (2012) Erythropoietin for Neuroprotection in Neonatal Encephalopathy: Safety and Pharmacokinetics. Pediatrics 130: 683-691. doi: 10. 1542/peds.2012-0498 PMID: 23008465
34. Brines M, Cerami A (2008) Erythropoietin-mediated tissue protection: reducing collateral damage from the primary injury response. Journal of Internal Medicine 264: 405-432. doi: 10.1111/j.1365-2796. 2008.02024.x PMID: 19017170
35. Iwai M, Liu JL, Yin W, Cao GD, Signore AP, et al. (2007) Erythropoietin enhances angiogenesis and neuronal replacement in cerebral cortex after neonatal hypoxia-ischemia. Stroke 38: 557-558.
36. Kertesz N, Wu J, Chen THP, Sucov HM, Wu H (2004) The role of erythropoietin in regulating angiogenesis. Developmental Biology 276: 101-110. PMID: 15531367
37. Ashley RA, Dubuque SH, Dvorak B, Woodward SS, Williams SK, et al. (2002) Erythropoietin stimulates vasculogenesis in neonatal rat mesenteric microvascular endothelial cells. Pediatric Research 51: 472-478. PMID: 11919332
38. Marti HH, Bernaudin M, Petit E, Bauer C (2000) Neuroprotection and angiogenesis: Dual role of erythropoietin in brain ischemia. News in Physiological Sciences 15: 225-229. PMID: 11390915
39. Carlini RG, Reyes AA, Rothstein M (1995) RECOMBINANT-HUMAN-ERYTHROPOIETIN STIMULATES ANGIOGENESIS IN-VITRO. Kidney International 47: 740-745. PMID: 7752572
40. Liu W, Shen Y, Plane JM, Pleasure DE, DengW(2011) Neuroprotective potential of erythropoietin and its derivative carbamylated erythropoietin in periventricular leukomalacia. Experimental Neurology 230: 227-239. doi: 10.1016/j.expneurol.2011.04.021 PMID: 21596035
41. Iwai M, Stetler RA, Xing J, Hu XM, Gao YQ, et al. (2010) Enhanced Oligodendrogenesis and Recovery of Neurological Function by Erythropoietin After Neonatal Hypoxic/Ischemic Brain Injury. Stroke 41: 1032-1037. doi: 10.1161/STROKEAHA.109.570325 PMID: 20360553
42. Byts N, Siren A-L (2009) Erythropoietin: a multimodal neuroprotective agent. Experimental & Translational Stroke Medicine 1: 1-4.
43. Sasaki R (2003) Pleiotropic functions of erythropoietin. Intern Med 42: 142-149. PMID: 12636232
44. Schultz C, Zimmer J, Haertel C, Rupp J, Temming P, et al. (2008) Attenuation of monocyte proinflammatory cytokine responses to Neisseria meningitidis in children by erythropoietin. Clinical and Experimental Immunology 154: 187-191. doi: 10.1111/j.1365-2249.2008.03760.x PMID: 18785973
45. Kumral A, Baskin H, Yesilirmak DC, Ergur BU, Aykan S, et al. (2007) Erythropoietin attenuates lipopoly-saccharide-induced white matter injury in the neonatal rat brain. Neonatology 92: 269-278. PMID: 17627093
46. Chong ZZ, Li FQ, Maiese K (2005) Erythropoictin requires NF-kappa B and its nuclear translocation to prevent early and late apoptotic neuronal injury during beta-amyloid toxicity. Current Neurovascular Research 2: 387-399. PMID: 16375720
47. Villa P, Bigini P, Mennini T, Agnello D, Laragione T, et al. (2003) Erythropoietin selectively attenuates cytokine production and inflammation in cerebral ischemia by targeting neuronal apoptosis. Journal of Experimental Medicine 198: 971-975. PMID: 12975460
48. Agnello D, Bigini P, Villa P, Mennini T, Cerami A, et al. (2002) Erythropoietin exerts an anti-inflammatory effect on the CNS in a model of experimental autoimmune encephalomyelitis. Brain Research 952: 128-134. PMID: 12363412
49. Arnold CC, Kramer MS, Hobbs CA, McLean FH, Usher RH (1991) Very low birth weight: a problematic cohort for epidemiologic studies of very small or immature neonates. Am J Epidemiol 134: 604-613. PMID: 1951265